Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-α

BACKGROUND AND PURPOSE: Combining statin and fibrate in clinical practice provides a greater reduction of triglycerides than either drug given alone, but the mechanism for this effect is poorly understood. Apolipoprotein AV (apoAV) has been implicated in triglyceride metabolism. This study was desig...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Huang, Xian-sheng, Zhao, Shui-ping, Bai, Lin, Hu, Min, Zhao, Wang, Zhang, Qian
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Publishing Ltd 2009
Assuntos:
Research Papers
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2765591/
https://ncbi.nlm.nih.gov/pubmed/19694729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2009.00350.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares